Photoleukomelanodermatitis of Kobori

From WikiMD's WELLNESSPEDIA


Photoleukomelanodermatitis of Kobori
Synonyms Kobori's photoleukomelanodermatitis
Pronounce N/A
Specialty Dermatology
Symptoms Skin pigmentation changes, hypopigmentation, hyperpigmentation
Complications N/A
Onset N/A
Duration N/A
Types N/A
Causes Photosensitivity reaction
Risks Exposure to ultraviolet light
Diagnosis Clinical evaluation, skin biopsy
Differential diagnosis N/A
Prevention N/A
Treatment Avoidance of UV light, topical corticosteroids
Medication N/A
Prognosis Generally good with avoidance of triggers
Frequency Rare
Deaths N/A


Photoleukomelanodermatitis of Kobori is a rare skin disorder characterized by the presence of both hyperpigmented and hypopigmented macules on the skin. It was first described by Japanese dermatologist Yasushi Kobori in 1978. The condition is also known as Kobori's disease.

Etiology[edit]

The exact cause of Photoleukomelanodermatitis of Kobori is unknown. However, it is believed to be associated with prolonged exposure to ultraviolet radiation, particularly UVB rays. Some researchers also suggest a possible genetic predisposition.

Symptoms[edit]

The primary symptom of Photoleukomelanodermatitis of Kobori is the appearance of irregularly shaped, dark brown and white patches on the skin. These patches are usually found on sun-exposed areas such as the face, neck, and arms. Other symptoms may include mild itching and a burning sensation.

Diagnosis[edit]

Diagnosis of Photoleukomelanodermatitis of Kobori is primarily based on clinical examination and patient history. Dermoscopy and skin biopsy may be used to confirm the diagnosis and rule out other skin conditions.

Treatment[edit]

There is currently no specific treatment for Photoleukomelanodermatitis of Kobori. Management of the condition primarily involves avoiding sun exposure and using sun protection measures such as sunscreen and protective clothing. Topical treatments such as hydroquinone and tretinoin may be used to lighten hyperpigmented areas.

Prognosis[edit]

The prognosis for Photoleukomelanodermatitis of Kobori is generally good. The condition is not life-threatening, but it can cause significant cosmetic concern for the patient. Regular follow-up with a dermatologist is recommended to monitor the condition and manage any symptoms.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.